Literature DB >> 27364559

MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

Li Su1, Yongli Luo1, Zhi Yang1, Jing Yang1, Chao Yao1, Feifei Cheng2, Juanjuan Shan1, Jun Chen1, Fangfang Li3, Limei Liu1, Chungang Liu1, Yanmin Xu1, Lupin Jiang4, Deyu Guo1, Jesus Prieto5, Matías A Ávila5, Junjie Shen6, Cheng Qian6.   

Abstract

Epithelial-mesenchymal transition (EMT) is an essential mechanism of metastasis, including in colorectal cancer. Although EMT processes are often triggered in cancer cells by their surrounding microenvironment, how EMT-relevant genes control these processes is not well understood. In multiple types of cancers, the transcription factor MEF2D has been implicated in cell proliferation, but its contributions to metastasis have not been addressed. Here, we show MEF2D is overexpressed in clinical colorectal cancer tissues where its high expression correlates with metastatic process. Functional investigations showed that MEF2D promoted cancer cell invasion and EMT and that it was essential for certain microenvironment signals to induce EMT and metastasis in vivo Mechanistically, MEF2D directly regulated transcription of the EMT driver gene ZEB1 and facilitated histone acetylation at the ZEB1 promoter. More importantly, MEF2D responded to various tumor microenvironment signals and acted as a central integrator transducing multiple signals to activate ZEB1 transcription. Overall, our results define a critical function for MEF2D in upregulating EMT and the metastatic capacity of colorectal cancer cells. Further, they offer new insights into how microenvironment signals activate EMT-relevant genes and deepen the pathophysiologic significance of MEF2D, with potential implications for the prevention and treatment of metastatic colorectal cancer. Cancer Res; 76(17); 5054-67. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27364559     DOI: 10.1158/0008-5472.CAN-16-0246

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  MEF2 transcription factors in human placenta and involvement in cytotrophoblast invasion and differentiation.

Authors:  Lucy Li; Lewis P Rubin; Xiaoming Gong
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

2.  SORBS2, mediated by MEF2D, suppresses the metastasis of human hepatocellular carcinoma by inhibitiing the c-Abl-ERK signaling pathway.

Authors:  Bin Yan; Zhiyong Peng; Chungen Xing
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

3.  MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D.

Authors:  Liang Liu; Sitong Cui; Rui Zhang; Yan Shi; Liangsheng Luo
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

4.  miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.

Authors:  Sinan Sun; Tianyi Hang; Boyu Zhang; Liang Zhu; Yang Wu; Xiangwei Lv; Qiang Huang; Hanhui Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  Overexpression and biological function of MEF2D in human pancreatic cancer.

Authors:  Zhiwang Song; Chan Feng; Yonglin Lu; Yong Gao; Yun Lin; Chunyan Dong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  MiR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D and modulating activities of Wnt/β-catenin signaling.

Authors:  Kai Li; Jin Pan; Jianjun Wang; Fengrui Liu; Li Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

7.  Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/β-catenin pathway.

Authors:  Wei Wang; Qing Li; Tao Yang; Dongsheng Li; Feng Ding; Hongzhi Sun; Guang Bai
Journal:  Cytotechnology       Date:  2018-02-17       Impact factor: 2.058

8.  Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D.

Authors:  Nianxu Luan; Yi Wang; Xuedong Liu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

9.  MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.

Authors:  Qing Xiao; Yaqi Gan; Yimin Li; Lili Fan; Jiaqi Liu; Pengyan Lu; Jiaxin Liu; Aoao Chen; Guang Shu; Gang Yin
Journal:  Oncogene       Date:  2021-04-16       Impact factor: 9.867

10.  KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.

Authors:  Yonglan Wang; Kun Cao
Journal:  J Immunol Res       Date:  2021-07-01       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.